COURSE OF NOCOSPITAL PNEUMONIA IN PATIENTS ON LONG-TERM ALV

COURSE OF NOCOSPITAL PNEUMONIA IN PATIENTS ON LONG-TERM ALV

Authors

  • Yusupov Shavkat Rakhimbaevich Urgench branch of the Tashkent Medical Academy, Urgench, Uzbekistan
  • Nurullaev Ruslan Rustambekovich Urgench branch of the Tashkent Medical Academy, Urgench, Uzbekistan
  • Masharipova Shokhista Sabirovna Urgench branch of the Tashkent Medical Academy, Urgench, Uzbekistan
  • Masharipov Sobir Masharipovich Urgench branch of the Tashkent Medical Academy, Urgench, Uzbekistan

Keywords:

Pneumonia, lung ventilation, patient, hospital, aspiration, bacterium.

Abstract

Hospital-acquired pneumonia (HP) accounts for 14 to 20% of the total structure of nosocomial infections, and ranks first in terms of mortality. The etiology of HP varies depending on the profile of the department and the microecological features of a particular hospital. The causative agents of HP are: P. aeruginosa, Enterobacter, E. coli, K. pneumoniae, Proteus spp., Serratia marcescens, H. influenzae, S. aureus, S. pneumoniae. In severe cases, highly resistant Gr (-) microorganisms (P. aeruginosa, Acinetobacter), methicillin-resistant S. aureus (MRSA), Candida spp., Aspergillus fumigatus, Pneumocysta carinii can be isolated. Legionella is responsible for less than 8% of HP cases. There are two variants of lung infection: the first is the endogenous route of infection (autoinfection); the second is an exogenous route of infection (from other patients or medical personnel), contaminated air, food, water, objects that come into contact with the patient's respiratory tract (bronchoscopes, catheters for sanitation of the tracheobronchial tree, etc.).

References

Heyland D. K., Cook D. J., Griffith L. et al. The atributable morbitidy and mortality of ventilator associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am. J. Respir. Crit. Care Med. 1999, 159 (4 Pt 1): 1249—1256.

Niederman M. S., Craven D. E., Fein A. M. et al. Pneumonia in the criti cally ill hospitalised patient. Chest 1990; 97 (1): 170—181.

Pingleton S. K., Fagon J. Y., Leeper K. V. Patient selection for clinical investigation of ventilatorassociated pneumonia. Criteria for evaluat ing diagnostic techniques. Chest. 1992; 102 (5 Suppl 1): 553S—556S.

Light R.B. Ventilator associated pneumonia: asking the right question. Thorax 1999; 54 (10): 863—864.

Rello J., Ausina V., Ricart M. et al. Impact of previous antimicrobial ther apy on the etiology and outcome of ventilatorassociated pneumonia. Chest 1993; 104 (4): 1230—1235.

Rello J., Quintana E., Ausina V. et al. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients, Chest 1991; 100 (2): 439—444.

Rello J., Ollendorf D. A., Oster G. et al. Epidemiology and outcomes of ventilatorassociated pneumonia in a large US database. Chest 2002, 122 (6): 2115—2121.

National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990 — May 1999, issue June 1999. An. J. Infect. Control 1999; 27: 520—532.

Fagon J. Y., Chastre J., Hance A. J. et al. Nosocomial pneumonia in ven tilated patients: a cohort study evaluating attributable mortality and hospital stay. Amer. J. Med. 1993; 94 (3): 281—288.

Downloads

Published

2022-12-01

How to Cite

Shavkat Rakhimbaevich, Y., Ruslan Rustambekovich, N., Shokhista Sabirovna, M. ., & Sobir Masharipovich, M. (2022). COURSE OF NOCOSPITAL PNEUMONIA IN PATIENTS ON LONG-TERM ALV. Education News: Exploring the 21st Century, 1(5), 569–572. Retrieved from http://nauchniyimpuls.ru/index.php/noiv/article/view/2407
Loading...